The Graduate Program in Biochemistry, Microbiology, and Molecular Biology, Department of Biochemistry and Molecular Biology.
Department of Veterinary and Biomedical Sciences, Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802.
Toxicol Sci. 2017 Nov 1;160(1):83-94. doi: 10.1093/toxsci/kfx160.
Chemokines are components of the skin microenvironment, which enable immune cell chemotaxis. Traditionally, transcription factors involved in inflammatory signaling (eg, NFκB) are important mediators of chemokine expression. To what extent xenobiotics and their associated receptors control chemokine expression is poorly understood. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor known to mediate physiological responses in the skin through the regulation of genes involved in xenobiotic metabolism, epidermal differentiation, and immunity. Here, we demonstrate that AHR activation within primary mouse keratinocytes regulates the expression of a neutrophil directing chemokine (C-X-C motif) ligand 5 (Cxcl5). AHR-mediated regulation of Cxcl5 is because of direct transcriptional activity upon treatment with AHR agonists such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Additionally, AHR mediates enhanced induction of Cxcl5 upon exposure to an agonist and the inflammatory cytokine interleukin 1 beta. This synergy is confined primarily to keratinocytes, as dermal fibroblasts did not achieve the same level of combinatorial induction. AHR-specific antagonists were able to reduce basal and induced levels of Cxcl5, demonstrating the potential for pharmacological intervention. Exposure of C57BL/6 J mice to ultraviolet (UV) light followed by topical treatment with the AHR agonist formylindolo(3,2-b)carbazole (FICZ) significantly induced Cxcl5 expression in skin compared with UV alone, and this response was absent in Ahr-/- mice. These results establish AHR as an important mediator of Cxcl5, with implications for the treatment of inflammatory skin diseases.
趋化因子是皮肤微环境的组成部分,能够使免疫细胞趋化。传统上,参与炎症信号转导的转录因子(例如 NFκB)是趋化因子表达的重要介质。外源性化学物质及其相关受体在多大程度上控制趋化因子的表达还知之甚少。芳烃受体(AHR)是一种配体激活的转录因子,已知通过调节参与外源性化学物质代谢、表皮分化和免疫的基因,介导皮肤中的生理反应。在这里,我们证明 AHR 在原代小鼠角质形成细胞中的激活调节了中性粒细胞定向趋化因子(C-X-C 基序)配体 5(Cxcl5)的表达。AHR 介导的 Cxcl5 调节是由于 AHR 激动剂(如 2,3,7,8-四氯二苯并对二恶英(TCDD))处理后的直接转录活性。此外,AHR 介导了在暴露于激动剂和炎症细胞因子白细胞介素 1β时 Cxcl5 的增强诱导。这种协同作用主要局限于角质形成细胞,因为真皮成纤维细胞无法达到相同水平的组合诱导。AHR 特异性拮抗剂能够降低 Cxcl5 的基础和诱导水平,表明存在药理学干预的潜力。与单独暴露于 UV 相比,C57BL/6J 小鼠暴露于紫外线(UV)光后用 AHR 激动剂 FICZ(formylindolo(3,2-b)carbazole)进行局部处理可显著诱导皮肤中 Cxcl5 的表达,而 Ahr-/- 小鼠则没有这种反应。这些结果确立了 AHR 作为 Cxcl5 的重要介质,这对治疗炎症性皮肤病具有重要意义。